Insurance and TRT

[saltydog1820]

Aetna - 200mg/week. No problems.

[durak]

Aetna Policy:
http://www.aetna.com/cpb/medical/data/500_599/0528.html

Clinical Policy Bulletin:
Androgens and Anabolic Steroids

Number: 0528

Policy

Note: Most policies specifically exclude coverage of steroids for performance enhancement. For plans without this exclusion, androgens and anabolic steroids, as well as other medical interventions for performance enhancement, are not covered because performance enhancement of non-diseased individuals is not considered treatment of disease or injury. Please check benefit plan descriptions for details.

Aetna considers anabolic steroids medically necessary for any of the following indications:

AIDS wasting syndrome; or
Anemia accompanying renal failure; or
Bone marrow failure anemias; or
Refractory red cell production anemias (including aplastic anemia, myelofibrosis, myelosclerosis, agnogenic myeloid metaplasia, hypoplastic anemias caused by malignancy or myelotoxic drugs); or
Weight loss from cancer chemotherapy; or
Breast cancer; or
Hereditary angioedema; or
Growth failure in children with growth hormone deficiency (treatment adjunct); or
Conditions associated with decreased fibrinolytic activity due to anti-thrombin III deficiency or fibrinogen excess (including cutaneous vasculitis, scleroderma of Raynaud's disease, vasculitis of Behcet's disease, complications of deep vein thrombosis such as venous lipodermatosclerosis, other vascular disorders associated with these forms of reduced fibrinolytic activity, and prevention of recurrent venous thrombosis associated with anti-thrombin III deficiency); or
Delayed male puberty (androgenic anabolic steroids); or
Constitutional delay in growth (androgenic anabolic steroids); or
Symptomatic androgen deficiency in men* (androgenic anabolic steroids) (see appendix); or
Microphallus (androgenic anabolic steroids); or
Endometriosis (danazol) (see CPB 327 - Infertility); or
Fibrocystic breast disease or mastalgia (danazol) (see CPB 512 - Premenstrual Syndrome/Premenstrual Dysphoric Disorder); or
Klinefelter's syndrome with hypogonadism (androgenic anabolic steroids) (see appendix).
* Injectable androgens are considered experimental and investigational for treatment of female menopause.

Aetna considers androgens and anabolic steroids experimental and investigational as a treatment for chronic obstructive pulmonary disease and for all other indications.

Background
Androgens and anabolic steroids include:

Testosterone
Methyltestosterone
Megesterol acetate
Fluoxymesterone
Oxandrolone
Oxymetholone
Stanozolol
Danazol.